Ana Saavedra

Barcelona, CT, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Social Memory and Social Patterns Alterations in the Absence of STriatal-Enriched Protein Tyrosine Phosphatase.

Social Memory and Social Patterns Alterations in the Absence of STriatal-Enriched Protein Tyrosine Phosphatase.

Journal: Frontiers in behavioral neuroscience

Published: August 02, 2018

Huntington's disease: novel therapeutic perspectives hanging in the balance.

Huntington's disease: novel therapeutic perspectives hanging in the balance.

Journal: Expert opinion on therapeutic targets

Published: April 20, 2018

Proteolytic Degradation of Hippocampal STEP61 in LTP and Learning.

Proteolytic Degradation of Hippocampal STEP61 in LTP and Learning.

Journal: Molecular neurobiology

Published: April 13, 2018

Age-related changes in STriatal-Enriched protein tyrosine Phosphatase levels: Regulation by BDNF.

Age-related changes in STriatal-Enriched protein tyrosine Phosphatase levels: Regulation by BDNF.

Journal: Molecular and cellular neurosciences

Published: July 18, 2017

Chelerythrine promotes Ca2+-dependent calpain activation in neuronal cells in a PKC-independent manner.

Chelerythrine promotes Ca2+-dependent calpain activation in neuronal cells in a PKC-independent manner.

Journal: Biochimica et biophysica acta. General subjects

Published: September 19, 2016

Cognitive dysfunction in Huntington's disease: mechanisms and therapeutic strategies beyond BDNF.

Cognitive dysfunction in Huntington's disease: mechanisms and therapeutic strategies beyond BDNF.

Journal: Brain pathology (Zurich, Switzerland)

Published: June 30, 2016

Caffeine-mediated BDNF release regulates long-term synaptic plasticity through activation of IRS2 signaling.

Caffeine-mediated BDNF release regulates long-term synaptic plasticity through activation of IRS2 signaling.

Journal: Addiction biology

Published: February 29, 2016

Down-regulation of BDNF in cell and animal models increases striatal-enriched protein tyrosine phosphatase 61 (STEP61 ) levels.

Down-regulation of BDNF in cell and animal models increases striatal-enriched protein tyrosine phosphatase 61 (STEP61 ) levels.

Journal: Journal of neurochemistry

Published: June 18, 2015

BDNF Induces Striatal-Enriched Protein Tyrosine Phosphatase 61 Degradation Through the Proteasome.

BDNF Induces Striatal-Enriched Protein Tyrosine Phosphatase 61 Degradation Through the Proteasome.

Journal: Molecular neurobiology

Published: January 23, 2015

Hyperactivation of D1 and A2A receptors contributes to cognitive dysfunction in Huntington's disease.

Hyperactivation of D1 and A2A receptors contributes to cognitive dysfunction in Huntington's disease.

Journal: Neurobiology of disease

Published: August 03, 2014

H2O2- or l-DOPA-injured dopaminergic neurons trigger the release of soluble mediators that up-regulate striatal GDNF through different signalling pathways.

H2O2- or l-DOPA-injured dopaminergic neurons trigger the release of soluble mediators that up-regulate striatal GDNF through different signalling pathways.

Journal: Biochimica et biophysica acta

Published: October 22, 2013

Regulation of hippocampal cGMP levels as a candidate to treat cognitive deficits in Huntington's disease.

Regulation of hippocampal cGMP levels as a candidate to treat cognitive deficits in Huntington's disease.

Journal: PloS one

Published: April 29, 2013

Showing 1-12 of 14

Last Updated: 09/26/2026